Last Price
149.86
Today's Change
-6.37 (4.07%)
Day's Change
149.86 - 149.86
Trading Volume
3
Profile
0JAV
Exchange: London Stock Exchange London Stock Exchange
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: William H. Lewis William H. Lewis
Full Time Employees: 1,271 1,271
IPO Date: 2018-01-29 2018-01-29
ISIN: US4576693075 US4576693075
Beta: 1.12 1.12
Last Dividend: 0.00 0.00
Dcf Diff: 231.51 231.51
Dcf: -81.65 -81.65
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Address
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Hock Soon Capital Berhad, a leading Malaysian egg producer, expands to meet growing local and regional demand, plans to list on the Main Market!](https://mqac.i3investor.com/img/video_thumbnail/1419/Thumbnail__(25).png)
Apps
Top Articles
1
Stumbling and Mumbling
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now